Skip to content
Review

Who is responsible? A risk-stratified framework for pharmacist accountability in artificial intelligence-assisted managed care.

Sep 2026 · Journal of Managed Care & Specialty Pharmacy · Vol 32 9, pp. 1130-1134 · 0 citations · 2 references
Medicine

TL;DR

A pharmacist-centered accountability framework for AI-assisted managed care decisions is proposed that emphasizes explicit professional responsibility, structured human-in-the-loop review, and documentation practices that support transparency and auditability.

Abstract

Artificial intelligence (AI)-enabled tools are increasingly integrated into managed care pharmacy workflows, particularly in utilization management and prior authorization processes. Although these systems aim to improve operational consistency and efficiency, federal regulatory guidance and professional standards make clear that coverage and medical necessity determinations must remain grounded in human clinical judgment. As AI tools become part of routine managed care, responsibility for final decisions may become unclear, creating an accountability gap. This article synthesizes federal regulatory guidance and professional pharmacy standards relevant to AI use in health care. We review Centers for Medicare & Medicaid Services requirements, oversight findings from the US Department of Health and Human Services Office of Inspector General, and established pharmacy ethics frameworks. Based on this review, we propose a pharmacist-centered accountability framework for AI-assisted managed care decisions. The framework emphasizes explicit professional responsibility, structured human-in-the-loop review, and documentation practices that support transparency and auditability. Clarifying pharmacist accountability in AI-assisted utilization management can strengthen professional stewardship, enhance workforce readiness, and support responsible innovation in managed care pharmacy.

View source

Similar papers

Review Sep 2026

A pharmacist-overseen, artificial intelligence-enabled model for provider-side prior authorization: From burden to opportunity (PAVE-1).

This viewpoint proposes a pharmacist-overseen, AI-enabled system designed for provider organizations and health systems as an optimal model, integrating clinical expertise across the AI system's design, triage logic, clinical review, and continuous improvement to ensure clinical rigor and operational efficiency.

Jorge A. Valedon Navarro, Rachel C. Reise · 0 citations
Editorial Open access Aug 2026

Ask-Audit-Apply: A Framework for Clinical Reasoning with Artificial Intelligence.

Ask-Audit-Apply (AAA) is proposed as a clinician-facing framework for AI-supported clinical reasoning that specifies decision-level behavioral practices that may support education, supervision, and future research on safe AI integration across a range of CDS tools as these systems increasingly participate in clinical c...

Andrew Jenkins, Katherine W. Eisenberg, R. Ziegelstein · 0 citations
Review Open access Sep 2026

Patient safety governance in artificial intelligence-enabled healthcare: a systematic review and the artificial intelligence patient safety governance model

Artificial intelligence (AI) is rapidly becoming part of everyday healthcare practice, helping hospitals and clinics diagnose diseases, recommend treatments, monitor patients and manage medical data. While these technologies offer significant opportunities to improve the quality and efficiency of healthcare, they also...

K. Falayi, Prince Chukwuemeka Ekeocha, Oladayo Mary Akintola et al. · 0 citations
Open access Sep 2026

Implications of the new US AI framework in medicine

How the new US AI framework may accelerate adoption while leaving clinically consequential tools outside traditional regulatory pathways is examined.

A. Armoundas · 0 citations
Review Open access Sep 2026

From Regulatory Authorization to Clinical Accountability: A Control Preventability Framework for Healthcare AI

A Control–Preventability Principle is proposed that allocates accountability according to control, foreseeability, preventability, and meaningful oversight capacity across developers, deploying institutions, and clinicians, with accountability following control over preventable risk rather than merely the physical loca...

Tony T. Williams, Amna Jatoi, Sazain Malik et al. · 0 citations

EDITORIAL TEAM

The study found that existing health and medical practice regulations remain oriented toward conventional healthcare relationships, and shared liability as a legal construction for distributing responsibility in AI-related healthcare malpractice is found to be inadequate.

Mochammad Tanzil Multazam, Hindarto, Yusuf Handyliem et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.